The Monitor Daily

Thursday, January 21, 2021
Log in

As a participant in the Amazon Services LLC Associates Program, this site may earn from qualifying purchases. We may also earn commissions on purchases from other retail websites.

  • Home
  • Politics & National News
  • Business News
  • Tech & Science
  • Health & Lifestyle
  • About us
    • Contact US
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Stormy Planet
    • US Surgeon Performs Face Transplant
    • 2017 MTV VMAs Nominations Are In And Voting Is Now Open
    • Bright House: Free McAfee AntiVirus and Adult Controls
    • Antarctic Yeti Crab Gets Formal Scientific Name
    • Spiders Take Over Australian Town
    • Interesting Facts About the Apollo 11 Mission
    • Social Smoking or The New Landmark of Elegance Among Young Women
    • Rare Weasel Returns To Washington State

Pages

  • About The Monitor Daily
  • Contact US
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use

Recent Posts

  • Precisely what is Administration Buyback? Feb 12, 2020
  • Precisely what is Administration Buyback? Feb 12, 2020
  • Where by do Registered requests get kept Dec 1, 2019
  • Find a Star of the event on the Submit Purchase New bride List May 19, 2019
  • Locate Really enjoy On the internet Apr 30, 2019
  • Get Love On the net Apr 12, 2019
  • NYC Man Snaps Photo of the Victim After Sucker-Punching Him in Broad Daylight Jun 29, 2018

Chronic Lymphocytic Leukemia Could be Treated with Immune Cell Therapy

By Leave a Comment

Researchers found that using immune cells to treat chronic lymphocytic leukemia or CLL improves the patients’ condition on the long run.

Researchers found that using immune cells to treat chronic lymphocytic leukemia or CLL improves the patients’ condition on the long run.

Researchers found that using immune cells to treat chronic lymphocytic leukemia or CLL improves the patients’ condition on the long run.

Some patients involved in the study were in full remission, while for others, the new therapy, dubbed CTL019, improved their life expectancy.

In a proof-of-concept study, researchers used the patients’ T cells – key for immune responses in the body – to seek and eventually kill the cancer cells. T cells are collected from the patients, reprogrammed to attack and reduce the number of blood cancer cells and transplanted in the patient.

According to lead researcher on the study, Dr. David Porter, who is the director of blood and marrow transplantation with the University of Pennsylvania Hospital:

“This is a new, ultra-personalized and precision approach to treating cancer”.

CTL019 is a new beam of hope for patients suffering from chronic lymphocytic leukemia, a blood cancer that is deemed the most common in adults. Typically, the life expectancy of patients with CLL varies from 2 to 20 years.

While conventional treatments targeting chronic lymphocytic leukemia are available, they do little to cure the disease. For instance, stem cell transplants, which is one of the latest approaches is a successful therapy. Yet, not all patients may benefit from the procedure, as they are not eligible.

As such, CTL019 comes to fill a gap in possible therapy options for CLL patients. The current study is a follow-up for a 2010 study during which 14 patients received the CTL019 treatment. At the time, all 14 participants in the study had chronic lymphocytic leukemia and had undergone other conventional therapies.

During the follow-up the researchers found that eight of 14 patients responded astonishingly well to CTL019. Four patients were found to be in complete remission. One had unfortunately died after 21 months, yet the death was due to an infection suffered after a different surgical procedure.

Four of the eight patients responded partially to the immune cell therapy. The average response lasted approximately seven months. In the follow-up sessions, two patients passed away as the disease progressed. The deaths occurred at 10 and 27 months after the CTL019 treatment was received.

Another six patients did not respond to the therapy. The T cells transplanted in their body did not follow the expected expansion necessary to attack the cancer cells. Nonetheless, cellular therapy such as this one is deemed to have a great potential, as the immune cells act as a ‘living drug’, persisting in the patient’s bodies for years and continuing to expand and be functional.

The therapy is still being perfected and studies are incipient. Yet, CTL019 has the potential to become one of the most successful therapies to fight chronic lymphocytic leukemia.

The results of the follow-up study can be found in the Science Translational Medicine.

Photo Credits: wikimedia.org

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Health & Lifestyle

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 34 other subscribers

Operation Paperclip

Remembering Georg von Tiesenhausen, Last Member of Von Braun’s Rocket Team

By Leave a Comment

giant ground sloths on white background

It Seems that Giant Sloths Once Roamed Earth, and Humans Used to Hunt Them? (Study)

By Leave a Comment

sn 2001ig supernova explosion and images of its stars

A Star Escaped a Supernova Explosion, and NASA Snapped its Picture

By Leave a Comment

ngc 6420 galaxy resembling a giant butterfly

Hubble Spots Giant Butterfly Formed by a Black Hole and Stellar Winds (Study)

By Leave a Comment

infrared image of a dog

Space Technology Could Help Protect Earth’s Endangered Species

By Leave a Comment

snake slithering on a beige background

Kirigami Skin Is Helping a Soft Robot Slither Like a Snake (Study)

By Leave a Comment

woolly mammoth

Ice Age Tracks Reveal How Young Mammoths Cared for Adult Ones (Study)

By Leave a Comment

High Priestess tomb.

Archaeologists Discovered 4400-Years-Old High Priestess Tomb Near Cairo

By Leave a Comment

dwarf galaxies

Dwarf Galaxies Challenge the Entire Dark Matter Cosmology (Study)

By Leave a Comment

NASA Scientists and Food Experiments

NASA Scientists to Test if Astronauts Could Eat Their Own Poo

By Leave a Comment

KFC Smoky Wings Box Can Turn into Awesome Drone

By Leave a Comment

Tesla Model S

Tesla Model S Involved in Autopilot Malfunction Accident

By Leave a Comment

Duke Nukem.

John Cena Cold Feature in Duke Nukem Movie

By Leave a Comment

Battlefield One

Battlefield One Apocalypse DLC to Land in February

By Leave a Comment

Related Articles

  • eye procedure

    Queensland Mother Mutilated After Non-Invasive Eye Procedure Goes Sideways

  • HIV

    Northwest Arkansas Man Sentenced to 50 Years in Prison for Contracting HIV with the Purpose of Infecting Others

  • Meditation

    Yale Scientists Pinpointed the Brain Area for Spiritual Experiences

  • artificial intelligence

    Artificial Intelligence Outperforms Dermatologist in Melanoma Diagnosis

  • pill

    Arlington Doctor Gets 3 Years in Prison for Slipping Abortion Pill in Woman’s Tea

  • back of woman with short gray hair

    New Study Proposes Another Possible Cause for Gray Hair (Study)

  • two people jogging

    Being Physically Active Can Reportedly Make You Happier (Study)

  • OCD Twins Commit Suicide

    OCD Twins Committed Suicide, Freemont County Sheriff Confirms

  • fingerprint

    You Might Have Traces of Class A Drugs on Your Fingerprints

  • Bariatric surgery

    Star of ‘My 600-Lbs Life’ Dies of Heart Attack Following Bariatric Surgery

Categories

  • Business News
  • Entertainment
  • Featured
  • Health & Lifestyle
  • Nature
  • Politics & National
  • Sports
  • Tech & Science
  • US
  • World

Copyright © 2021 TheMonitorDaily.com

About · Privacy Policy · Terms of Use · Sitemap · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.